The Medical Oncology Centre of Rosebank

Institution (Healthcare)

Homepage ROR

Also Known As

The Medical Oncology Centre of Rosebank

461

Publications

19.2K

Citations

Authors

138

Concepts

About

The Medical Oncology Centre of Rosebank is a healthcare institution in Johannesburg, South Africa known for medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	67	4.6K
2	Health Sciences	8	12	459
3	Engineering	3	3	67
4	Natural Sciences	2	3	78
5	Business	1	1	25

The Medical Oncology Centre of Rosebank

461

Publications

19.2K

Citations

Page 1

	Year	Citations
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3) Fátima Cardoso, A. Costa, Elżbieta Senkus, Annals of Oncology	2016	2.1K
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4) Fátima Cardoso, Elżbieta Senkus, A. Costa, Annals of Oncology	2018	1.1K
Management of febrile neutropaenia: ESMO Clinical Practice Guidelines Jean Klášterský, Julien de Naurois, K. V. I. Rolston, Annals of Oncology Febrile NeutropaeniaClinical Case ReportClinical ReviewClinical EpidemiologyMedicine	2016	720
2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients Fausto Roila, Alex Molassiotis, Jørn Herrstedt, Annals of Oncology Radiation MedicineRadiation TherapyGastrointestinal OncologyMedicineAdvanced Cancer Patients	2016	569
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) Fátima Cardoso, A. Costa, Larry Norton, Annals of Oncology	2014	537
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2) Fátima Cardoso, A. Costa, Larry Norton, The Breast	2014	328
Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma Jason Chesney, Antoni Ribas, Georgina V. Long, Journal of Clinical Oncology	2022	241
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study Bernardo L. Rapoport, Karin Jordan, Judith A. Boice, Supportive Care in Cancer Emetogenic ChemotherapiesOncologyChemotherapy-induced NauseaGastrointestinal OncologyPharmacology	2009	233
3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3) Fátima Cardoso, A. Costa, Elżbieta Senkus, The Breast Advanced Breast CancerSurgical OncologyBreast OncologyHealth SciencesMedicine	2016	230
Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy M. Marty, Marc Espié, Alain Monnier, Annals of Oncology Breast OncologyOncologyMedicineAnthracycline-based ChemotherapyBreast Cancer	2006	192

Page 1